Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2009.03946.xPMID 19183147
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms

  2009cited by this paper
• Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

  2008cited by this paper
• Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography.

  2008cited by this paper
• A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal Neoplasia

  2007cited by this paper
• Sensitivity of Immunochemical Fecal Occult Blood Test to Small Colorectal Adenomas

  2007cited by this paper
• Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme

  2007cited by this paper
• Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme

  2007cited by this paper
• Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

  2007cited by this paper
• Colorectal Screening after Polypectomy: A National Survey Study of Primary Care Physicians

  2006cited by this paper
• Prevalence of clinically important histology in small adenomas.

  2006cited by this paper
• Comparison of a brush‐sampling fecal immunochemical test for hemoglobin with a sensitive guaiac‐based fecal occult blood test in detection of colorectal neoplasia

  2006cited by this paper
• Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review.

  2006cited by this paper
• Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.

  2006cited by this paper
• Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.

  2006cited by this paper
• Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.

  2006cited by this paper
• Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

  2006cited by this paper
• Microsatellite instability in interval colon cancers.

  2006cited by this paper
• Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology

  2005cited by this paper
• Utilization of colonoscopy in the United States: results from a national consortium.

  2005cited by this paper
• A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

  2005cited by this paper
• Colorectal cancer: how bis is the problem, why prevent it, and how might it present?

  2005cited by this paper
• Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.

  2005cited by this paper
• Sensitivity of immunochemical fecal occult blood test for colorectal flat adenomas.

  2004cited by this paper
• Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population

  2003cited by this paper
• Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood

  2002cited by this paper
• Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer.

  2001cited by this paper
• Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study

  2000cited by this paper
• Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests

  2000cited by this paper
• A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer.

  2000cited by this paper
• Colorectal adenomatous polyps detected by immunochemical occult blood screening.

  1998cited by this paper
• Detection rate of immunochemical fecal occult blood test for colorectal adenomatous polyps with severe dysplasia

  1997cited by this paper
• Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies.

  1997cited by this paper
• Clinico-pathological features of colorectal adenomatous polyps with negative results on immunochemical fecal occult blood test.

  1997cited by this paper
• Endoscopic and histologic correlates of colorectal polyp bleeding.

  1995cited by this paper
• Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

  1993cited by this paper
• The National Polyp Study

  1990cited by this paper
• The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas.

  1990cited by this paper
• Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity.

  1990cited by this paper
• Risk factors for blood loss from adenomatous polyps of the large bowel: a colonoscopic evaluation with histopathological correlation.

  1988cited by this paper

• Utility of Stool-Based Tests for Colorectal Cancer Detection: A Comprehensive Review

  2024cites this paper
• Adenoma location, size, and morphology are risk factors for FOBT false-negative results in inpatients with advanced colorectal adenoma

  2024cites this paper
• The Sensitivity and the Specificity of the Fecal Immunochemical Testing in Detecting Colonic Cancerous and Precancerous Lesions among the Lebanese Population

  2023influential citation
• Effectiveness and Harms of Colorectal Cancer Screening Strategies.

  2022cites this paper
• The potential of fecal microbiota and amino acids to detect and monitor patients with adenoma

  2022cites this paper
• A Multi-Centre Study to Risk Stratify Colorectal Polyp Surveillance Patients Utilising Volatile Organic Compounds and Faecal Immunochemical Test

  2022cites this paper
• Future Prospects of Colorectal Cancer Screening: Characterizing Interval Cancers

  2021cites this paper
• Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm

  2021cites this paper
• Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: Study protocol.

  2021cites this paper
• Early detection and follow‐up of colorectal neoplasia based on faecal volatile organic compounds

  2020cites this paper
• Analysis of volatile organic compounds released from SW480 colorectal cancer cells and the blood of tumor-bearing mice

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Usefulness of risk stratification models for colorectal cancer based on fecal hemoglobin concentration and clinical risk factors.

  2019cites this paper
• Fecal immunochemical test in cancer screening – colonoscopy outcome in FIT positives and negatives

  2019cites this paper
• Incidence of interval cancers in faecal immunochemical test colorectal screening programmes in Italy

  2018cites this paper
• Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study

  2018cites this paper
• Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients

  2017cites this paper
• Interval cancers in a guaiac-based colorectal cancer screening programme: Consequences on sensitivity

  2017cites this paper
• Which Fecal Immunochemical Test Should I Choose?

  2017cites this paper
• Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity

  2017cites this paper
• Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany

  2017cites this paper
• Fecal hemoglobin concentration is useful for risk stratification of advanced colorectal neoplasia.

  2016cites this paper
• Características del cáncer de colon detectado en una segunda ronda de cribado tras una primera ronda negativa

  2016cites this paper
• Faecal immunochemical screening tests for colorectal cancer: a single-centre case study from the Czech Republic

  2016cites this paper
• Developments in Screening Tests and Strategies for Colorectal Cancer

  2015cites this paper
• Which adenomas are detected by fecal occult blood testing? A state‐wide analysis from Bavaria, Germany

  2015cites this paper
• Histological features of advanced colorectal adenomas detected by endoscopy and fecal immunochemical test

  2015cites this paper
• Fecal immunochemical testing results and characteristics of colonic lesions

  2015cites this paper
• Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study

  2014cites this paper
• Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?

  2014cites this paper
• The Performance of Three-Sample Qualitative Immunochemical Fecal Test to Detect Colorectal Adenoma and Cancer in Gastrointestinal Outpatients: An Observational Study

  2014cites this paper
• Diagnostic accuracy of a single qualitative immunochemical fecal occult blood test coupled with physical measurements

  2014cites this paper
• Characteristics of Adenomas Detected by Fecal Immunochemical Test in Colorectal Cancer Screening

  2014cites this paper
• Sequential Combination of Serum Pyruvate Kinase Isoenzyme M2 and Colonoscopy-A Promising Screening Protocol for Colorectal Cancer Early Diagnosis

  2013cites this paper
• average colorectal cancer risk Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with

  2013cites this paper
• Colorectal cancer screening: From test performance to participant experience

  2013cites this paper
• Comparison of the performance of guaiac‐based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan

  2013cites this paper
• Are Fecal Immunochemical Test Characteristics Influenced by Sample Return Time? A Population-Based Colorectal Cancer Screening Trial

  2012cites this paper
• Similar fecal immunochemical test results in screening and referral colorectal cancer.

  2012cites this paper
• Follow-up of patients undergoing both semiquantitated immunochemical fecal occult blood and colonoscopy examinations

  2012cites this paper
• Improvements in colorectal cancer screening programmes - quantitative immunochemical faecal occult blood testing - how to set the cut-off for a particular population.

  2012cites this paper
• Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review

  2011cites this paper
• Test Performance of Immunologic Fecal Occult Blood Testing and Sigmoidoscopy Compared with Primary Colonoscopy Screening for Colorectal Advanced Adenomas

  2011cites this paper
• Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia

  2011cites this paper
• Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study

  2011cites this paper
• A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study

  2011cites this paper
• Stool DNA Screening for Colorectal Cancer: Opportunities to Improve Value With Next Generation Tests

  2011cites this paper
• Indirect Comparison of Two Quantitative Immunochemical Faecal Occult Blood Tests in a Population with Average Colorectal Cancer Risk

  2011cites this paper
• The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy

  2011cites this paper
• Correction

  2011cites this paper
• Immunochemical faecal occult blood tests have superior stability and analytical performance characteristics over guaiac-based tests in a controlled in vitro study

  2011cites this paper
• Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?

  2010cites this paper
• Inter‐test agreement and quantitative cross‐validation of immunochromatographical fecal occult blood tests

  2010cites this paper
• Performance improvements of stool-based screening tests.

  2010cites this paper
• Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use

  2010cites this paper
• Practical advances in stool screening for colorectal cancer.

  2010cites this paper
• Sex Differences in Performance of Fecal Occult Blood Testing

  2010cites this paper
• Colonic Polyps and Polyposis Syndromes

  2010cites this paper
• Combining the tests did not lead to improved performance

  2009cites this paper